Skip to main content
. 2020 Aug 27;12(9):2432. doi: 10.3390/cancers12092432

Figure 5.

Figure 5

Figure 5

Model overview. (a). Decision model for both strategies incorporating CE-CT and 18F-FDG PET/CT. For each outcome, a Markov model analysis was performed; (b). Markov model with potential states “No recurrence”, “Hepatic recurrence only”, “Any other recurrence” and “Death”. The first state was determined depending on the outcomes in the decision model.